What's Going On: Innovations in Treating Heart Disease. Philabundance and Addressing Hunger

On this episode of What's Going On, we explore two conversations centered on health, hope, and strengthening our communities. First, we welcome David St. Denis, President of Anteris Technologies, for an important discussion about why heart disease remains the leading cause of death for women in the United States and why women with heart valve disease are often diagnosed later and experience poorer outcomes than men. We discuss aortic stenosis, the symptoms women should never ignore, the importance of early diagnosis, and the promise of the investigational DurAVR® Transcatheter Heart Valve, a next-generation technology designed to more closely replicate the function of a healthy heart valve. David also explains why greater representation of women in clinical research is critical and shares practical advice on how women can become stronger advocates for their heart health.  Then, we feature a special segment produced by Kimberly Wang, one of our Philadelphia Youth Network WorkReady students. Kimberly sits down with Pamela Rainey Lawler, founder of Philabundance, to discuss the organization's ongoing fight against hunger across the Greater Philadelphia and Delaware Valley region. Their conversation explores how Philabundance is responding to changes affecting SNAP benefits, new initiatives to address food insecurity, and simple ways individuals can make a meaningful difference in their own communities. Whether you're interested in protecting your heart health or helping build a stronger, more food-secure community, this episode offers information and inspiration you won't want to miss.   Resources – Anteris TechnologiesWebsite: https://anteristech.comDurAVR® Clinical Evidence: https://anteristech.comNews & Investor Center: https://anteristech.com/newsLinkedIn: Anteris TechnologiesX: @AnterisTechHeart Health ResourcesAmerican Heart Association – Go Red for Women: https://www.goredforwomen.orgCDC – Heart Disease in Women: https://www.cdc.gov/heartdisease/women.htmPhilabundanceWebsite: https://www.philabundance.orgFacebook: PhilabundanceInstagram: @philabundanceX: @PhilabundanceLinkedIn: PhilabundanceDurAVR® is an investigational device and is not approved for commercial sale. Discussion of the technology reflects ongoing clinical research and development.